Boston Scientific
BSX
843 hedge funds and large institutions have $50B invested in Boston Scientific in 2020 Q3 according to their latest regulatory filings, with 80 funds opening new positions, 326 increasing their positions, 302 reducing their positions, and 73 closing their positions.
9% more capital invested
Capital invested by funds: $45.8B → $50B (+$4.19B)
10% more first-time investments, than exits
New positions opened: 80 | Existing positions closed: 73
8% more repeat investments, than reductions
Existing positions increased: 326 | Existing positions reduced: 302
0% more funds holding
Funds holding: 840 → 843 (+3)
0.29% more ownership
Funds ownership: 91.34% → 91.63% (+0.29%)
18% less funds holding in top 10
Funds holding in top 10: 17 → 14 (-3)
65% less call options, than puts
Call options by funds: $119M | Put options by funds: $338M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$524M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$319M |
| 3 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$266M |
| 4 |
BlackRock
New York
|
+$181M |
| 5 |
Lazard Asset Management
New York
|
+$110M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$895M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$239M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$145M |
| 4 |
American Century Companies
Kansas City,
Missouri
|
-$111M |
| 5 |
D.E. Shaw & Co
New York
|
-$98M |
BSX Hedge Fund Activity: Q3 2020 in Review
843 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q3 2020, worth a combined $50B — up 9.1% from $45.8B a quarter earlier.
Buyers outnumbered sellers: 80 funds opened new BSX positions and 73 closed out — a net gain of 7 holders — while 326 added to existing stakes and 302 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $524M. The largest seller was Capital World Investors, cutting an estimated $895M.
- 843 institutional investors held Boston Scientific (BSX) as of Q3 2020, up from 840 in Q2 2020.
- Funds reported $50B of Boston Scientific stock for Q3 2020, up 9.1% quarter-over-quarter.
- 80 funds opened new Boston Scientific positions in Q3 2020 and 73 closed out, a net change of +7 holders.
- The largest Boston Scientific buyer in Q3 2020 was T. Rowe Price Associates, an estimated $524M added.
- The largest Boston Scientific seller in Q3 2020 was Capital World Investors, an estimated $895M sold.
Based on aggregated 13F filings for Q3 2020.